3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Classical hematology
1
Breast
1
Conditions
Uterine Cervical Neoplasms
3
Ovarian Neoplasms
3
Sleep Initiation and Maintenance Disorders
2
Neoplasms
2
Lung Neoplasms
2
Depression
2
Colorectal Neoplasms
2
Breast Neoplasms
2
Anxiety Disorders
2
Uterine Neoplasms
1
Sleep Wake Disorders
1
Psychological Trauma
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Pain
1
Multiple Myeloma
1
Melanoma
1
Lymphoma
1
Leukemia
1
Hepatitis B
1
Glioblastoma
1
Genetic Predisposition to Disease
1
Gallstones
1
Fatigue
1
Fanconi Anemia, Complementation Group D1
1
Esophageal Neoplasms
1
Carcinoma, Hepatocellular
1
Interventions
olaparib
5
talazoparib
1
liposomal doxorubicin
1
Trabectedin
1
Surveys and Questionnaires
1
Genetic Counseling
1
Demography
1
Data Collection
1
Counseling
1
Cognitive Behavioral Therapy
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Fanconi Anemia, Complementation Group D1
×
Cognitive Behavioral Therapy
×
Gynecologic
×
Clear all
NCT03889171
2019-03-28
PSICOM
University Hospital, Montpellier
Completed
200 enrolled